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Edited by Takashi GojoboriAbstract We isolated and characterized four new PKCd iso-
forms, PKCdIV, dV, dVI, and dVII, speciﬁcally expressed in
the mouse testis. These isoforms possess neither V1 nor C2-like
domains. Moreover, PKCdVI and dVII have a diﬀerent last exon
as their V5 domain. The transcription of PKCdIV, dV, dVI, and
dVII is initiated from the same site in the upstream region of
exon4 of the PKCd gene. They are expressed exclusively in the
testis in an age-dependent manner. PKCdIV and dV are ex-
pressed in spermatids with sperm maturation stage-speciﬁc man-
ner, and that PKCdVI and dVII are expressed in spermatogonia
and spermatocytes.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Protein kinase C (PKC) is a family of serine/threonine ki-
nases that play crucial roles in cellular signal transduction
[1]. Members of the PKC family are divided into three groups
based on their molecular structures and activating mecha-
nisms: (i) conventional PKC (a, b, and c isoforms) requiring
calcium, phosphatidylserine (PS), and diacylglycerol (DG)
for activation; (ii) novel PKC (d, e, g, and h isoforms) acti-
vated independently of calcium; and (iii) atypical PKC (f
and k/i isoforms), which are independent of both calcium
and DG for activation. Alternative splicing-derived variants
of PKC have been reported for the b, d, h, and f isoforms,
i.e., PKCbII [2], PKCdII [3], PKCdIII [4], PKChII [5], and
fII [6].
In 1987, PKCd was cloned from a rat brain cDNA library
[7]. PKCd is expressed ubiquitously in various cells and tissues,
suggesting that it has general rather than tissue- or cell-type-
speciﬁc roles in mammals [8]. The sequence of PKCdI contains
the following domains: N-terminal V1, the C2-like, the V2, the
C1 regulatory, the V3, the C3/V4/C4 catalytic, and the C-ter-Abbreviation: PKC, protein kinase C
q Genbank Accession Number: The cDNA sequences of PKCdIV, dV,
dVI, and dVII have been deposited in the GenBank with Accession
Nos. AB201453, AB201454, AB201455, and AB201456, respectively.
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the sequences necessary for Ca2+ co-ordination, and, therefore
PKCdI is activated by DG and phospholipids in a Ca2+-inde-
pendent manner. Three PKCd isoforms, viz. the original PKCd
as PKCdI, PKCdII [3], and rat PKCdIII [4], have been already
reported. PKCdII is insensitive to caspase-3 because PKCdII
has an insertion at the caspase-3 recognition sequence in the
V3 region [3]. Rat PKCdIII has only the V1, C2-like, and V2
regulatory domains, without the catalytic domain because
the 83 bp insertion in the V3 region causes inframe termination
[4].
PKCd is also implicated in the induction and execution pro-
grammed cell death or apoptosis [9], in response to some spe-
ciﬁc signals, including ionizing radiation [10], tumor necrosis
factor alpha [11], agonistic Fas antibody [12], H2O2[13], etopo-
side [14,15], phorbol esters [16], and ceramide [17,18].
PKCd has been reported to inhibit the proliferation of vari-
ous cells in a cell-type-speciﬁc manner [14,17,19], and to facil-
itate the diﬀerentiation of keratinocytes by inducing cell-cycle
arrest [20,21]. Extensive studies have also demonstrated that
PKCd plays important roles in the regulation of several impor-
tant cellular responses, such as diﬀerentiation, cell growth, and
apoptosis [8,22].
There are several reports describing PKC molecules ex-
pressed in mammalian testis [5,23–26]. One of these papers re-
ported that PKChII is produced by a testis speciﬁc
transcription system [5]. PKChII is expressed in the seminifer-
ous tubules of adult mouse testis and does not have the V1/C1
regulatory domain.
In the present study, we isolated four new PKCd isoforms,
PKCdIV, dV, dVI, and dVII, speciﬁcally expressed in mouse
testis. They are generated by alternative splicing of the PKCd
gene. PKCdIV and dV show spermatocyte maturation stage-
speciﬁc expression, and PKCdVI and dVII are expressed in
spermatogonia and spermatocytes in seminiferous tubules.
The PKCd gene transcribes for at least six isoforms by alterna-
tive splicing in mouse testis, indicating that PKCd consists
a large family and PKCd isoforms carry out testis speciﬁc
functions.2. Materials and methods
2.1. Animals
ICR mice (Japan SLC, Inc. Shizuoka, Japan) were housed in a room
of the animal facilities at Showa University maintained at 21 ± 1 C
and 50 ± 10% relative humidity with a 12 h light–dark cycle, and were
provided standard chow (Picolab mouse diet 20; Laboratory Diet,blished by Elsevier B.V. All rights reserved.
T. Kawaguchi et al. / FEBS Letters 580 (2006) 2458–2464 2459Brentwood, MO, USA) and water ad libitum. The experimental proto-
col was approved by The Institutional Animal Care and Use Commit-
tee of Showa University.
2.2. Northern blot analysis
Total RNA from the testis of 0-, 1-, 2-, 3-, 4-, 6-, 8-, and 12-week-old
ICR mice and from the whole brain of 12-week-old ICR mouse were
puriﬁed with a QuickPrep Total RNA extraction kit (Amersham Phar-
macia Biotech, UK). Total RNA samples isolated from mice testes
were subjected to Northern blot analysis, as shown in Fig. 1A and C
(20 lg/lane). Total RNA puriﬁed from brain and testis of 12-week-
old mouse were also subjected to blotting as shown in Fig. 1B
(10 lg/lane). RNA samples were electrophoresed on 1% agarose gels
containing formaldehyde, transferred to Hybond-N membrane (Amer-
sham Pharmacia Biotech, UK) and hybridized with the random-prime-
labeled cDNA probe which contained the entire coding region of
PKCd (37–1961 bp, GenBank Accession No. M69042). This cDNA
fragment was ampliﬁed by PCR using a pair of primers P-7 and P-8
(Table 1) with PKCd containing plasmid as a template.
2.3. Library screening and DNA sequencing
The mouse testis cDNA library prepared from CD-1 mouse testis
(Stratagene, CA) was screened using a random-prime-labeled cDNA
probe. This probe cDNA was ampliﬁed by PCR in ExTaq using
cDNAs of 8-week-old mouse testis as templates and a primer set ofFig. 1. PKCd expression in mouse testis by Northern blot analysis. (A)
Total RNA from mouse testis and brain were hybridized with full
length PKCd cDNA as probe. Positions of 28S and 18S rRNA are
indicated on the left side. (B) Total RNA from 0-, 1-, 2-, 3-, 4-, 6-, 8-,
and 12-week-old mice testes was hybridized with full length PKCd
cDNA as a probe. (C) The same samples in B were electrophoresed
onto an agarose gel and stained with ethidium bromide.
able 1
ist of primers used for PCR
rimer name Gene Region Direction
-G3 G3PDH Sense 5 0-ACCACAGTCCATGCCATCAC
-G3 G3PDH Antisense 5 0-TCCACCACCCTGTTGCTGTA
-1 PKCdI, II exon 3 Sense 5 0-AGGGAAGACACTGGTACAGA
-2 PKCdI, II exon13 Antisense 5 0-ATGTGGAACATCAGGTCACC
-3 PKCdIV, V exon 4a Sense 5 0-GTTCTGAGTCTCACCTGGGTCA
-4 PKCdIV, V exon 18 Antisense 5 0-CAGGAACTCTGGGTCAAAGT
-5 PKCdVI, VII exons 9,10 Sense 5 0-CAAGTGACCCAGAGATCTTC
-6 PKCdVI, VII exon 18a Antisense 5 0-CTGAGATTGCGAGGATGCAA
-7 PKCdI, II exon 2 Sense 5 0-CAATTCCTATGAGCTGGGCT
-8 PKCdI, II exon 18 Antisense 5 0-CGATGAGGTTCTTGTCACTG
-9 PKCdI, II exon 4 Sense 5 0-AAGGTGCTGATGTGTGTGCA
-10 PKCdI, II exon 5 Antisense 5 0-GATAAACTCGTGGTTCTTGA
-11 PKCdI, II, III, IV exon 18 Sense 5 0-CAGCAACTTTGACCCAGAGT
-12 PKCdI, II, III, IV exon 18 Antisense 5 0-CAGTTCACAGAGGAAGTACTG
-13 PKCdI, II exon 2 Sense 5 0-ATGGCACCCTTCCTGCGCAT
-14 PKCdI, II exon 3 Antisense 5 0-ACTCAGCCTTGCCGTTGTTC
-15 PKCdVI, VII exon 18a Sense 5 0-TGCAAGCCTGCTTCCTGACC
-16 PKCdVI, VII exon 18a Antisense 5 0-GGTGGTGCTGAGATTCAAACT
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PP-9 and P-10 was used for PCR reaction (Table 1). Forty ﬁve clones
were isolated and subjected to DNA sequencing with an automatic se-
quencer (ABI PRISM 310 Genetic Analyzer, Foster City, CA, USA).
2.4. RT-PCR of various tissues
Total RNA from the testis of 0-, 1-, 2-, 3-, 4-, 6-, 8-, and 12-week-old
mice and other tissues (brain, heart, lung, liver, kidney, spleen, ovary,
and muscle from 8-week-old mice) were puriﬁed with a QuickPrep To-
tal RNA extraction kit (Amersham Pharmacia Biotech, UK). Five
micrograms of total RNA was reverse-transcribed with SuperScriptII
(Life Technologies, Inc) and ampliﬁed in ExTaq under the following
PCR conditions: 2 min at 94 C, 30 cycles of 1 min at 94 C, 1 min
at 58 C, and 2 min 72 C, followed by 7 min at 72 C. The pairs of
primers used were P-1/P-2 for PKCdI and dII, P-3/P-4 for PKCdIV
and dV, and P-5/P-6 for PKCdVI and dVII. The PCR products were
subjected to electrophoresis on 1% agarose gel and visualized with
SYBR Green I (Molecular Probes, OR). cDNA concentrations were
normalized to the G3PDH content.
2.5. Western blot analysis
Full-length cDNA of PKCdI, dII, dIV, and dV were cloned into
pEF-BOS expression plasmid [27] and transfected using Lipofect-
AMINE 2000 (Life Technologies, Inc) into HEK293 cells grown Dul-
becco’s modiﬁed Eagle’s medium containing 10% fetal calf serum.
Transfected HEK293 cells as well as testis from 8-week-old mouse
(50 mg each) were sonicated in sample buﬀer for Western blotting
and aliquots of each samples were subjected to immunoblotting with
anti-PKCd antibody against the C-terminal peptide for PKCdI, dII,
dIV, and dV (nPKCd (C-17), Santa Cruz Biotechnology, Santa Cruz,
CA).
2.6. In situ hybridization
The PCR products ampliﬁed using pairs of primers P-11/P-12 for
PKCdI, dII, dIV, and dV, P-13/P-14 for PKCdI and dII, and P-15/P-
16 for PKCdVI and dVII (Fig. 2, Table 1), were sub-cloned into pBlue-
scriptII sk() plasmid. Plasmids containing each PKCd cDNA
fragment were linearized at ether end with EcoRI or HindIII. These
products were used as templates to synthesize digoxigenin-labeled anti-
sense and sense riboprobes with T3 or T7 RNA polymerase. Ribo-
probes were synthesized using the DIG RNA labeling Kit from
Roche diagnostics GmbH (Penzberg, Germany) according to the pro-
tocol supplied. Testicular tissues from 8-week-old mice were ﬁxed in
Bouin’s solution for 12 h at 4C. The ﬁxed tissues were washed several
times in 70% ethanol and processed for paraﬃn embedding. Sections
were cut at 6 lm and mounted onto mas-coated glass slides fromMats-
unami (Osaka, Japan). After hydration in a graded ethanol series, par-
aﬃn sections were prehybridized for 1h in hybridization solution (50%
deionized formamide, 4 · SSC, 10% dextran sulfate, 1 ·Denhart’s
solution, 2 mM EDTA, and 0.5 mg/ml sonicated salmon sperm
Fig. 2. Schematic structures of the cDNAs of mouse PKCd isoforms
(A) and their genomic DNA (B). (A) The cDNAs of PKCdI and dII
consist of variable V1, V2, V3, V4, and V5 domains and conserved C2-
like, C1, C3, and C4 domains. The C1 regulatory domain contains a
pseudosubstrate sequence and two cysteine-rich zinc ﬁnger motifs.
PKCdIV, dV, dVI, and dVII consist of V2, C1, V3, C3/V4/C4, and V5
domains. Black bar, (A), (B), and (C), probes for in situ hybridization
to detect PKCdI and dII, PKCdI, dII, dIV, and dV, and PKCdVI and
dVII, respectively. Blue, 78 bp insertion in V3 domain; purple,
PKCdIII speciﬁc exon with 83 bp insertion in V3 domain; gray; frame
shifted region due to 83 bp insertion; and yellow, speciﬁc exon for
PKCdVI and dVII. (B) Schematic structures of the PKCd genome.
Exons are indicated by orange, red, blue, purple, and yellow boxes and
numbered according to the report on the mouse genome by Suh et al.
[39]. Red, exon4a; blue, 78 bp insertion in the V3 region; purple,
PKCdIII speciﬁc exon with 83 bp insertion; yellow, speciﬁc exon for
PKCdVI and dVII; M, the ﬁrst methionine; and asterisks, the
termination codon. Introns are shown with horizontal lines. PKCd-
isoform-characteristic exons are shown under the schematic structures
of the whole PKCd genomic DNA.
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tion buﬀer at 50 C with either the antisense or sense riboprobe in a
humidiﬁed chamber. Sections were washed three times for 10 min at
50 C with wash buﬀer containing 60% formamide and 0.2 · SSC.
After incubation in blocking solution (0.1 M Tris–HCl, pH 7.5,
0.15 M NaCl, and 1.5% blocking mix (Roche diagnostics GmbH,
Penzberg, Germany)) for 30 min, the sections were incubated with
1:4000 alkaline phosphatase-conjugated anti-digoxigenin antibody
(Roche diagnostics GmbH, Penzberg, Germany) overnight at 4 Cand then reactivity detected using the BCIP/NBT substrate system
(DAKO, CA, USA). Alkaline phosphatase reactions were performed
for 72 h (dI and dII), 48 h (dVI and dVII) and 20 h (dI, dII, dIV, and
dV). After stopping the reaction, the section were counterstained with
hematoxylin.2.7. 5 0-Rapid ampliﬁcation of cDNA ends
The 5 0-end of PKCdIV, dV, dVI, and dVII mRNAs were determined
using the 5 0RACE kit (version 2, Life Technologies, Inc., Gaithers-
burg, MD) according to the conditions suggested by the manufacturer.
PCR products were sub-cloned into pBluescriptII sk() plasmid and
sequenced with an ABI PRISM 310 Genetic Analyzer.3. Results and discussion
3.1. Isolation of PKCdIV, dV, dVI, and dVII cDNA
Northern blot analysis of total RNA from the mouse brain
and testis revealed two transcriptional products corresponding
to bands of 2.8 kb mRNA in the brain and 2.1 kb mRNA in
the testis with full length PKCd cDNA as a probe (Fig. 1A).
Some reports indicated that the original nPKCd molecule
showed a similar 2.8 kb band in following Northern blot anal-
ysis [23,26].
To identify the transcript of the 2.1 kb band, we screened a
mouse testis cDNA library and isolated 45 independent clones
containing the entire coding region. These 45 clones were di-
vided into four new PKCd isoforms, termed PKCdIV, dV,
dVI, and dVII.
The cDNA clones of PKCdIV, dV, dVI, and dVII were 2139,
2215, 1927, and 2005 bp, respectively. To the clone of
PKCdIV, 46 nucleotides had been added by 5 0-RACE of
mouse testis mRNA. To PKCdV, dVI, and dVII, 37, 48, and
34 nucleotides, respectively, had been added. Transcription
of PKCdIV, dV, dVI, and dVII started at the same site and
possibly an open reading frame, initiated from the ﬁrst methi-
onine, Met116 of PKCdI, coded for 559, 585, 545, and 571 ami-
no acids, respectively. We adopted the ﬁrst methionine as a
starting site because of the presence of an in-frame stop codon
upstream. Those four isoforms contained the V2, C1 regula-
tory, V3, C3/V4/C4 catalytic, and V5 domains. They had
neither the V1 domain nor the C2-like domain (Fig. 2). The
C2-like domain is similar to the C2, Ca2+-binding domain,
but has no Ca2+-binding ability, as it lacks the sequences nec-
essary for Ca2+ co-ordination [28]. Some reports indicated that
this domain has key roles for the protein–protein interactions
involved in regulating intracellular translocation and redistri-
bution of PKCd molecule. It was reported that PKCdI was
translocated from the cytosol to the plasma membrane
through interaction with growth associated protein 43
(GAP43) [29] and with receptors for activated PKC (RACKs)
[30]. Moreover, F-actin has been reported to bind to PKCdI
through its C2-like domain, that is important in regulating ac-
tin redistribution in neutrophils [31]. These data suggest that
interaction with other protein through C2-like domain may
be unnecessary for PKCdIV, dV, dVI, and dVII in the testis.
PKCdV and dVII retained the 26 amino acid insertion in the
V3 domain. In the V3 domain, there was a Caspase-3 cleavage
site into which 26 amino acids had been inserted. PKCdII con-
tained the identical insertion sequence at the same site in V3
domain. The amino acid sequence, DILD, of PKCdI from
D324 to D327, is a Caspase-3 recognition site. The sequence
DILD changes to DILG due to 78 bp insertion in PKCdII,
Fig. 4. Tissue distribution of PKCd isoforms. Total RNAs puriﬁed
from brain, heart, lung, liver, kidney, spleen, ovary, testis, and muscle
of 8-week-old mice were subjected to RT-PCR for PKCd isoform
mRNA. The primers used for RT-PCR are indicated in Table 1.
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whereas PKCdII was not [3]. PKCdVI and dVII had a new
V5 sequence at their C-terminus, indicating that the last exon
of PKCdVI and dVII was replaced with a new exon as the V5
domain. It was reported that PKCbI and bII were produced by
alternative splicing of the C-terminal last exon of the V5 do-
main [2]. The V5 domain of PKCbI and bII may function in
intracellular localization [32,33] and various physiological
roles [34–36]. Recently, it was reported that the V5 region of
PKCd contains determinants critical to its nuclear distribution
[37]. Thus, the V5 domain is critical for isozyme-speciﬁc func-
tions. These reports suggested that the intracellular localiza-
tion of PKCdVI and dVII diﬀers from that of PKCdIV and
dV due to their diﬀerent V5 region. The molecular structures
of PKCdIV, dV, dVI, and dVII are compared with that of
PKCdI and dII in Fig. 2A.
3.2. Genomic structure of PKCd gene
The gene of PKCd, named prkcd, was mapped to chromo-
some 3 in human and 14 in mouse [38]. The genomic sequence
of mouse PKCd was already reported on GenBank, Accession
No. AF274044. Analysis of this sequence with the data of 5 0-
RACE revealed that the ﬁrst exon of PKCdIV, dV, dVI, and
dVII started to transcribe 154 bp upstream of exon 4 of PKCdI
[39], indicating that the elongated form to 5 0 upstream of exon
4, named exon 4a in the present paper, was the ﬁrst exon of
these testis-speciﬁc PKCd isoforms(Figs. 2B and 3A). This is
suggesting that the testis speciﬁc promoter for PKCd gene
may be located in the upstream region of exon4a. The V5 do-
main of PKCdI is consisted with one last exon, exon 18 in the
present paper. In the case of PKCdVI and dVII, the diﬀerent
exon, named exon 18a, was chosen by alternative splicing as
the V5 domain. Exon 18a was located between exon 17 and
18 (Figs. 2B and 3B). As the V5 domain of PKC may function
intracellular localization [34,35,39], PKC PKCdVI and dVII
may localize diﬀer from other PKC molecules. PKCdV and
dVII had a 78 bp insertion sequence in the V3 domain as inFig. 3. Genomic DNA sequences of new exons for PKCdIV, dV, dVI, and dV
Capital and lower letters indicate the exons and introns, respectively. Exons
indicated by a dashed line. The ﬁrst methionine, the stop codon, and poly (PKCdII. This insertion is likely to induce Caspase-3 insensitive
PKCd molecules.
At least six isoforms of PKCd are expressed in mouse testis.
These isoforms are derived by alternative splicing, and their
molecular structures are complex. This observation indicates
that each domain of PKCd has an important role in their iso-
form-speciﬁc functions. So far, there are no report recognizing
the expression of PKCdIII from mouse PKCd gene. Fig. 2B
summarizes the generation of all PKCd isoforms cDNAs from
the PKCd gene by alternative usage of exons.
3.3. Tissue distribution of PKC isoforms
To demonstrate that PKCd isoforms existed in vivo, total
RNA was isolated from various mouse tissues, brain, heart,
lung, liver, kidney, spleen, ovary, testis, and muscle, and sub-
jected to reverse transcription. The tissue distribution of PKCd
isoforms was analysed by RT-PCR using primers P-1 and P-2
for ampliﬁcation of PKCdI and dII, P-3 and P-4 for PKCdIV
and dV, and P-5 and P-6 for PKCdVI and dVII. Identiﬁcation
of these bands was conﬁrmed by comparison with the mobility
of DNA fragments ampliﬁed from corresponding plasmid
standards (data not shown). Expression levels were normalized
to GAPDH. PKCdI and dII were not expressed together in any
tissues (Fig. 4). The one band with primers P-1 and P-2 wasII. A, DNA sequence and splicing junction of exon 4a and B, exon18a.
are boxed. The unique sequences of PKCdIV, dV, dVI, and dVII are
A) adenylation signal are under lined.
Fig. 6. Protein expression of PKCdI, dII, dIV, dV in mouse brain,
testis, and their overexpressing HEK293 cells. 8-Week-old mouse brain
(lane 1), HEK293 cells overexpressing PKCdI (lane 2), HEK293 cells
overexpressing PKCdII (lane 3), 8-week-old mouse testis (lane 4),
HEK293 cells overexpressing PKCdIV (lane 5), and HEK293 cells
overexpressing PKCdV (lane 6).
2462 T. Kawaguchi et al. / FEBS Letters 580 (2006) 2458–2464PKCdI, determined from the mobility of DNA fragments.
PKCdI was expressed ubiquitously. PKCdIV–dVII were ex-
pressed speciﬁcally in the testis (Fig. 4). In the lane of testis,
there are two bands in the experiment of PKCdIV, dV and
PKCdVI, dVII. The upper band corresponds to PKCdV, dVII
and the lower band to PKCdIV and PKCdVI. These data indi-
cated that PKCdVI, dV, dVI, and dVII are expressed and func-
tion speciﬁcally in the testis.
3.4. Age-dependent expression of PKCd isoforms
In mouse testis, spermatogenesis starts shortly after birth
and germ cell diﬀerentiation from stem cell to sperm is com-
plete in approximately one month. Age-dependent expression
of PKCd isoforms was analyzed by Northern blot analysis
and RT-PCR using total RNA from newborn, 1-, 2-, 3-, 4-,
6-, 8-, and 12-week-old mice. Northern blot analysis showed
that PKCd was expressed in the new-born testis and that its
expression level was increased from 4weeks until adulthood
(Fig. 1B). Details of PKCd isoform expression were revealed
by RT-PCR (Fig. 5). The primers used for ampliﬁcation of
PKCd isoforms are summarized in Table 1. The PCR products
expected to contain PKCdI and dII showed only one band cor-
responding to PKCdI, indicating that PKCdII is not expressed
in the testis. PKCdI was expressed at birth and its expression
was increased until 3 weeks of age and decreased thereafter.
On the other hand, the expressions of PKCdIV, dV, dVI,
and dVII was ﬁrst detected at 4-week-old and increased there-
after with age until adulthood (Fig. 5), meaning that these
PKCd isoforms function in the testis from 4-week-old to adult
stage. Moreover the expression levels of PKCdIV and dV were
almost equal, as were the expression of PKCdVI and dVII.
These results suggested that PKCdIV, dV, dVI, and dVII are
involved in maturation in the testis and/or androgen produc-
tion and response.
3.5. Expression of PKCd at the protein level
PKCdIV was expressed at the protein level in the mouse tes-
tis, and in the cells overexpressing its cDNAs. In Fig. 6, total
proteins of testis and brain from 8-week-old mouse as well
as from HEK293 cells transfected with PKCdI, dII, dIV, and
dV cDNAs were subjected to immunoblotting with the anti-
body against to the C-terminal peptide for PKCdI, dII, dIV,
and dV. In the brain, we can see the expression of PKCdI. A
band corresponding to the molecular mass of PKCdIV
(65 kDa) was detected in the testis and PKCdIV transfected
cells, whereas a band corresponding to PKCdI was seen in
the brain and PKCdI expressing cells. PKCdII was not de-
tected in the brain, nor was PKCdV in the testis. This data
indicated that PKCdI and dIV are mainly expressed in the
brain and testis, respectively, and that PKCdII and dV mayFig. 5. Age-dependent expressions of PKCd isoforms in mouse testis.
Total RNAs puriﬁed from 0-, 1-, 2-, 3-, 4-, 6-, 8-, and 12-week-old mice
testis were subjected to RT-PCR. The primers used for RT-PCR are
indicated in Table 1.function in some speciﬁc circumstances. We have no antibody
recognizing PKCdVI or dVII because of their unique C-termi-
nus. The products of PKCdIV and dV were detected in the cells
transfected with the corresponding cDNAs.
3.6. Localizations of PKCd isoforms in mouse testis by in situ
hybridization analysis
Testis is composed of two important components, (i) the
seminiferous tubules producing the male germ cells, and (ii)
the interstitium producing androgen. In order to determine
the speciﬁc pattern of expression of PKCd isoforms, in situ
hybridization was performed on 8-week-old mice testis with
probes for, (i) PKCdI and dII, (ii) PKCdI, dII, dIV, and dV,
and (iii) PKCdVI and dVII, respectively. As described in mate-
rial and method, to get these images, Fig. 7A, C, and E, neces-
sitated alkaline phosphatase reaction times were 72, 20, and
48 h, respectively. The results of in situ hybridization showed
that: (i) PKCdI and dII were weakly expressed in all cells inFig. 7. In situ hybridization of PKCd isoforms in mouse testis.
Paraﬃn sections of 8-week-old mouse testis were hybridized with DIG
labeled probes. A and B, PKCdI and dII; C and D, PKCdI, dII, dIV,
and dV; E and F, PKCdVI and dVII. A, C, and E, antisense; B, D, and
F, sense.
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pressed in germ cells with stage dependency (Fig. 7C), and
(iii) PKCdVI and dVII were expressed in spermatogonia and
spermatocytes (Fig. 7E).
Mammalian spermatogenesis is a complex cellular diﬀerenti-
ation pathway that occurs in three phases: (i) spermatogonia
multiplication, (ii) meiosis, and (iii) spermatogenesis. During
spermatogenesis, spermatids undergo dramatic changes in
both gene expression and cellular structure [40]. For more de-
tailed information on the stage-speciﬁc expression of PKCdIV
and dV, higher magniﬁcation analysis was performed. Fig. 8
showed that PKCdIV and dV were expressed in the round
spermatids at stages VII and VIII, and in the elongating sper-
matids at stages IX–XII. The expression level of PKCdIV and
dV was highest during stage VIII to XII, disappeared in the
late spermatid phase, and was absent in the spermatozoa
(Fig. 8). Taken together with these results, PKCdIV and dV
may be involved in gene expression and/or the changes of cel-
lular structure in spermatids at stages VII–XII; PKCdVI and
dVII may function in spermatogonia multiplication.
Overexpression studies of PKCd during apoptosis indicate
that PKCdI could induce apoptosis via its 40 kDa catalytically
active fragment [12], full length fragment [16], and kinase neg-
ative fragment [41]. Many reports suggest that PKCd plays a
major role in apoptosis. In mammalian testis, spontaneous
apoptosis of germ cells is common [42]. Damaged germ cells
are removed by selective apoptosis, which presumably prevents
transmission of genetic abnormalities to oﬀspring [43]. Pro-
grammed cell death of germ cells is important for maintaining
the integrity of germ cells and fertility. The intracellular local-
ization of PKCdIV and dV, the role of PKCd in apoptosis, and
spontaneously occurring apoptosis in germ cells, all indicateFig. 8. Stage-speciﬁc localization of PKCdI, dII, dIV and dV mRNA
in mouse testis by in situ hybridization. Roman numerals show the
stages of mouse spermatogenesis.that PKCd isoforms, speciﬁcally expressed in the testis, may
function to keep germ cells normal by removing abnormal
cells.
Two diﬀerent groups reported the ﬁndings on PKCd null
mice [44,45]. Leitges et al. described that PKCd/ mice devel-
oped normally and were fertile [44]. Miyamoto et al. did not
report if PKCd null mice were normally fertile or not [45]. In
null mice, Leitges et al. altered the exon containing the ﬁrst
methionine, (exon2 in this paper), and replaced it with a LacZ
gene. This replacement has no eﬀect on transcription of
PKCdIV, dV, dVI, and dVII. Another null mice strain was gen-
erated by replacing part of the region where a testis-speciﬁc
promoter may be located to neomycin resistance gene reported
by Miyamoto et al. If those PKCd null mice were fertile, there
is no conﬂict between the assumption that PKCdIV, dV, dVI,
and dVII function on apoptosis in germ cells, and that PKCd
null mice were fertile.
Further studies are needed for elucidating the mechanisms
by which the members of the PKCd family, including
new PKCd isoforms, mediate their involvement in spermato-
genesis.
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